Regulatory T cells that express high levels of IL-1R and ICOS display transcriptional features of antigen specificity, are highly suppressive and distinguish tumors from non-malignant inflamed tissues
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Martins, F. et al. Nat. Rev. Clin. Oncol. 16, 563–580 (2019).
Mair, F. et al. Nature 605, 728–735 (2022).
Greene, E. et al. Patterns (N Y) 2, 100372 (2021).
Browaeys, R., Saelens, W. & Saeys, Y. Nat. Methods 17, 159–162 (2020).
Ahmadzadeh, M. et al. Sci. Immunol. https://doi.org/10.1126/sciimmunol.aao4310 (2019).
Jain, A., Song, R., Wakeland, E. K. & Pasare, C. Nat. Commun. 9, 3185 (2018).
Fu, T., He, Q. & Sharma, P. Cancer Res. 71, 5445–5454 (2011).
Simpson, T. R. et al. J. Exp. Med. 210, 1695–1710 (2013).
Solomon, I. et al. Nat. Can. 1, 1153–1166 (2020).
Kidani, Y. et al. Proc. Natl Acad. Sci. USA 119, e2114282119 (2022).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Gálvez-Cancino, F., Lladser, A. & Quezada, S.A. Deciphering immunoregulatory vulnerabilities in human cancers. Nat Immunol 23, 995–996 (2022). https://doi.org/10.1038/s41590-022-01251-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-022-01251-w